372 related articles for article (PubMed ID: 17618575)
21. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
[TBL] [Abstract][Full Text] [Related]
22. Suppressive effects of DNA vaccines encoding heat shock protein on Helicobacter pylori-induced gastritis in mice.
Todoroki I; Joh T; Watanabe K; Miyashita M; Seno K; Nomura T; Ohara H; Yokoyama Y; Tochikubo K; Itoh M
Biochem Biophys Res Commun; 2000 Oct; 277(1):159-63. PubMed ID: 11027657
[TBL] [Abstract][Full Text] [Related]
23. Porcine interleukin-2 gene encapsulated in chitosan nanoparticles enhances immune response of mice to piglet paratyphoid vaccine.
Yang Y; Chen J; Li H; Wang Y; Xie Z; Wu M; Zhang H; Zhao Z; Chen Q; Fu M; Wu K; Chi C; Wang H; Gao R
Comp Immunol Microbiol Infect Dis; 2007 Jan; 30(1):19-32. PubMed ID: 17034859
[TBL] [Abstract][Full Text] [Related]
24. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
Strindelius L; Filler M; Sjöholm I
Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
[TBL] [Abstract][Full Text] [Related]
25. Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice.
Taylor JM; Ziman ME; Huff JL; Moroski NM; Vajdy M; Solnick JV
Vaccine; 2006 Jun; 24(23):4987-94. PubMed ID: 16621176
[TBL] [Abstract][Full Text] [Related]
26. Peroral immunization with Helicobacter pylori adhesin protein genetically linked to cholera toxin A2B subunits.
Kim BO; Shin SS; Yoo YH; Pyo S
Clin Sci (Lond); 2001 Mar; 100(3):291-8. PubMed ID: 11222115
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background.
Sutton P; Doidge C; Pinczower G; Wilson J; Harbour S; Swierczak A; Lee A
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):213-9. PubMed ID: 17567282
[TBL] [Abstract][Full Text] [Related]
28. Improved immune responses in mice using the novel chitosan adjuvant ViscoGel, with a Haemophilus influenzae type b glycoconjugate vaccine.
Neimert-Andersson T; Hällgren AC; Andersson M; Langebäck J; Zettergren L; Nilsen-Nygaard J; Draget KI; van Hage M; Lindberg A; Gafvelin G; Grönlund H
Vaccine; 2011 Nov; 29(48):8965-73. PubMed ID: 21945255
[TBL] [Abstract][Full Text] [Related]
29. Eradication of Helicobacter pylori and resolution of gastritis in the gastric mucosa of IL-10-deficient mice.
Matsumoto Y; Blanchard TG; Drakes ML; Basu M; Redline RW; Levine AD; Czinn SJ
Helicobacter; 2005 Oct; 10(5):407-15. PubMed ID: 16181351
[TBL] [Abstract][Full Text] [Related]
30. [Intranasal priming with HIV DNA vaccine and systemic boosting with recombinant vaccinia induce vigorous immune responses: experiment with mice].
Huang XG; Xu JQ; Ren L; Qiu C; Zhang N; Liu LX; Wan YM; Peng H; Shao YM
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3109-13. PubMed ID: 17313761
[TBL] [Abstract][Full Text] [Related]
31. Transcutaneous immunization with novel lipid-based adjuvants induces protection against gastric Helicobacter pylori infection.
Hickey DK; Aldwell FE; Tan ZY; Bao S; Beagley KW
Vaccine; 2009 Nov; 27(50):6983-90. PubMed ID: 19800441
[TBL] [Abstract][Full Text] [Related]
32. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
Nyström-Asklin J; Adamsson J; Harandi AM
Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
[TBL] [Abstract][Full Text] [Related]
33. Increased interleukin-10 in Helicobacter pylori infection could be involved in the mechanism protecting from allergy.
Oderda G; Vivenza D; Rapa A; Boldorini R; Bonsignori I; Bona G
J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):301-5. PubMed ID: 17873741
[TBL] [Abstract][Full Text] [Related]
34. Oral immunization of mice with attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
Liu X; Hu J; Zhang X; Fan D
Chin Med J (Engl); 2002 Oct; 115(10):1513-6. PubMed ID: 12490099
[TBL] [Abstract][Full Text] [Related]
35. Preparation and evaluation of anti-Helicobacter pylori efficacy of chitosan nanoparticles in vitro and in vivo.
Luo D; Guo J; Wang F; Sun J; Li G; Cheng X; Chang M; Yan X
J Biomater Sci Polym Ed; 2009; 20(11):1587-96. PubMed ID: 19619399
[TBL] [Abstract][Full Text] [Related]
36. [Interaction of Helicobacter polyri and indomethacin in gastric mucosa injury of Balb/c mice].
Ji KY; Hu FJ; Li AD; Li J
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):726-30. PubMed ID: 12899745
[TBL] [Abstract][Full Text] [Related]
37. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
Yang J; Dai LX; Pan X; Wang H; Li B; Zhu J; Li MY; Shi XL; Wang BN
Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25846576
[TBL] [Abstract][Full Text] [Related]
38. The protective immunity produced in infected C57BL/6 mice of a DNA vaccine encoding Schistosoma japonicum Chinese strain triose-phosphate isomerase.
Zhu Y; Si J; Ham DA; Yu C; He W; Hua W; Yin X; Liang Y; Xu M; Xu R
Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):207-13. PubMed ID: 12236413
[TBL] [Abstract][Full Text] [Related]
39. Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model.
Zavala-Spinetti L; Breslin MB; Correa H; Bégué RE
Helicobacter; 2006 Dec; 11(6):517-22. PubMed ID: 17083372
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of immunogenicity and protection efficacy of the recombinant hypoxanthine-guanine-xanthine of plasmodium falciparum in mice].
Xiao JY; Zhang DM; Cai LS; Shen LH; Pan WQ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Jun; 24(3):192-5. PubMed ID: 17094620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
